4 completed. 4 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Myxofibrosarcoma: new trials by email Literature Review of Myxofibrosarcoma trials Research Report on Myxofibrosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma CAB-AXL-ADC, PD-1 inhibitor - Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma | Phase 1 / Phase 2 | Completed | BioAtla, Inc. | 245 | 2018-02-15 | 2025-09-23 |
| Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma Dexrazoxane, Doxorubicin - Sarcoma, Soft Tissue, Soft Tissue Sarcoma | Phase 2 | Completed | Washington University School of Medicine | 73 | 2016-02-22 | 2023-11-07 |
| Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Doxorubicin, Doxorubicin Hydrochloride, Ifosfamide - Alveolar Soft Part Sarcoma, Angiomatoid Fibrous Histiocytoma | Phase 2 / Phase 3 | Completed | National Cancer Institute (NCI) | 140 | 2014-08-12 | 2026-06-17 |
| Alisertib in Treating Patients With Advanced or Metastatic Sarcoma Alisertib, Laboratory Biomarker Analysis - Myxofibrosarcoma, Recurrent Adult Soft Tissue Sarcoma | Phase 2 | Completed | National Cancer Institute (NCI) | 72 | 2012-08-22 | 2017-11-30 |
Dermatofibrosarcoma (4) · Histiocytoma, Malignant Fibrous (4) · Leiomyosarcoma (3) · Liposarcoma (3) · Neurofibrosarcoma (3) · Sarcoma (3) · Fibrosarcoma (2) · Sarcoma, Synovial (2) · Chondrosarcoma, Extraskeletal Myxoid (1) · Chondrosarcoma, Mesenchymal (1) · Granuloma, Plasma Cell (1) · Hemangiosarcoma (1) · Histiocytoma, Angiomatoid Fibrous (1) · Neoplasms (1) · Nerve Sheath Neoplasms (1)
Histiocytoma (4) · Neoplasms by Histologic Type (4) · Neoplasms, Connective Tissue (4) · Neoplasms, Connective and Soft Tissue (4) · Neoplasms, Fibrous Tissue (4) · Neoplasms (3) · Neoplasms, Adipose Tissue (3) · Neoplasms, Muscle Tissue (3) · Neoplasms, Nerve Tissue (3) · Nervous System Diseases (3) · Nervous System Neoplasms (3) · Neurofibroma (3) · Neuromuscular Diseases (3) · Peripheral Nervous System Diseases (3) · Peripheral Nervous System Neoplasms (3)
Doxorubicin (2) · Dexrazoxane (1) · Ifosfamide (1) · Immune Checkpoint Inhibitors (1) · MLN 8237 (1) · Radiation (1) · Radiotherapy (1) · Razoxane (1) · pazopanib (1)
National Cancer Institute (NCI) (2) · BioAtla, Inc. (1) · Washington University School of Medicine (1)
United States (4) · Canada (1) · Hong Kong (1) · Puerto Rico (1) · Taiwan (1)
Aaron R Weiss (1) · Brian A Van Tine, M.D., Ph.D. (1) · Mark Dickson (1)
PMID 27502708, PMID 32702309, PMID 32827353, PMID 34515544, PMID 37523624, PMID 38579194
U10CA031946 (1), U10CA098543 (1), U10CA180821 (1), U10CA180830 (1), U10CA180886 (1)